You noted that, in the ‘old days’, the pharma business had the following characteristics: first of all, it was a molecule-driven business, fueled by blockbuster medicines…
In Conversation
Dr. McLoughlin, you were appointed to your post in April of this year. Can you please give us an impression of what you inherited at this…
“ Dr. Duffy, how has Pfizer’s investment in Ireland evolved over time? ”
“ Dr. Mitchell, what attracted you to join Novartis after a decades-long career at Astrazeneca? ”
Interview with Alois Stöger, Federal Minister of Health Austria, Austrian Federal Ministry of Health
What are the historical and strategic factors which position Austria as one of the best healthcare systems in the world today? The main principles of the…
You have been with Bayer for almost 15 years. What would you say defines your loyalty to the company, and has the time so far met…
Mr. Zimmermann, you came to manage the Irish affiliate of Bayer in 2010, after heading Business Management for Bayer Pharma Headquarters in Berlin. After these two…
What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a…
Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact from research investments.”…
What initially attracted you to Biotest back in 2001 and what do you think attracts industry professionals to Biotest today? I started my pharmaceutical career at…
You previously worked as CSO for onepharm; what was the motivation for creating Savira? OS: When I was working at onepharm, the organization was focused on…
If we had to run shy of being competitive, I don’t believe that we would be driving in the right lane in this industry.'
